Clinical Trials Logo

Clinical Trial Summary

Acute kidney injury (AKI) is a major organ failure in septic shock. Current medical tests (serum creatinine and urea) cannot identify AKI until approximately 48 hours after it occurs. Neutrophil gelatinase-associated lipocalin (NGAL) may be able to predict ischemic AKI more effectively and faster than serum creatinine and urea levels.

The purpose of this study is to take a blood sample from patients at admission and then at 24 and 48 hours after to test their plasma for NGAL and compare the NGAL levels to their creatinine and urea levels. The investigators hypothesize that NGAL is an earlier marker to classify the kidney failure as acute tubular necrosis or pre-renal azotemia than creatinine and urea.


Clinical Trial Description

Primary Outcome Measures:

To correlate elevated serum NGAL with the diagnosis of intrinsic acute kidney injury in septic shock

Secondary Outcome Measures :

To compare serum NGAL with serum creatinine, serum urea and urine output in septic AKI Death within the intensive care unit Death from all causes at 28 days after inclusion ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01122225
Study type Observational
Source Université Victor Segalen Bordeaux 2
Contact
Status Active, not recruiting
Phase N/A
Start date July 2009
Completion date June 2010

See also
  Status Clinical Trial Phase
Recruiting NCT00760591 - Change of Neutrophil Gelatinase-Associated Lipocalin(NGAL) Following Sodium Phosphate Bowel Preparation(Pilot Study) N/A
Completed NCT00890214 - Prostacyclin's Effect on Platelet Responsiveness Phase 4
Active, not recruiting NCT03675906 - The Relationship Between Hypoalbuminemia and Development of Acute Kidney Failure (AKI) According to KDIGO Criteria
Recruiting NCT04334707 - Kidney Precision Medicine Project
Active, not recruiting NCT04079829 - Postoperative Respiratory Abnormalities
Recruiting NCT00424320 - Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy Phase 3
Completed NCT00472563 - Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate Phase 2/Phase 3
Withdrawn NCT03846258 - High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy Phase 4
Completed NCT06358365 - Enhancing Fluid Transfer Through the Skin, by Increased Sweat Rate, on Hemodialysis Patients N/A
Completed NCT00252200 - BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery. Phase 1/Phase 2
Completed NCT04190979 - Clinical Application of the Medyria TrackCath System in Endovascular Repair of Abdominal Aortic Aneurysms (AAA) N/A
Completed NCT04917497 - Levosimendan Infusion in Critically Ill Patients With Cardiogenic Shock
Recruiting NCT05309291 - Theranova Randomized, Controlled, Trial (RCT) in China N/A
Completed NCT02486614 - Effect of Citrate on the Coagulation System in Patients Receiving CRRT
Active, not recruiting NCT02470507 - Immune Function in Acute Kidney Injury
Active, not recruiting NCT05384899 - Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol
Completed NCT06190522 - Diagnosis of Acute Obstructive Renal Failure by Clinical Ultrasound Performed by the Emergency Physician.
Recruiting NCT04221932 - Implementation of CRRT KPI Reports to Standardize and Improve the Quality of CRRT Delivery in Alberta "QUALITY CRRT"
Completed NCT00529139 - Hannover Dialysis Outcome Study Phase 4
Recruiting NCT04445779 - Q10 Preloading Before Cardiac Surgery for Kidney Failure Reduction N/A